Table 1.
MDD | HC | Statistical values | |||
---|---|---|---|---|---|
Mean | SD | Mean | SD | ||
Sex (m/f) | 17/17 | 36/42 | = 0.141; p = 0.71 | ||
Age (years) | 37.4 | 9.9 | 37.3 | 7.2 | t(110) = 0.093; p = 0.93 |
Education (years) | 15.7 | 2.2 | 15.1 | 2 | t(101) = 1.357; p = 0.18 |
eIQ | 112 | 8 | 107.5 | 9.3 | t(110) = 2.440; p = 0.02 |
CESD | 20 | 14 | 8.1 | 5.2 | = 4.391; p < 0.001 |
SSS | 2.74 | 0.51 | 2.54 | 0.73 | = 1.631; p = 0.11 |
HAMD | 7.12 | 6.29 | |||
GAF | 57.4 | 16.4 | |||
IMP | 96.5 | 151.9 | |||
CP | 48.1 | 105.1 | |||
DZP | 4.9 | 8.7 |
MDD, major depressive disorder; HC, healthy control; SD, standard deviation; m: male; f, female; eIQ, estimated (premorbid) intelligence quotient; SSS, Stanford sleepiness scale; HAMD, 17-item Hamilton rating scale for depression; CESD, Center for Epidemiologic Studies depression scale; GAF, global assessment of functioning; IMP, imipramine equivalent of antidepressant dosage; CP, chlorpromazine equivalent for antipsychotic dosage; DZP, diazepam equivalent for anxiolytic dosage.
*The degrees of freedom were adjusted for CESD and SSS because the equality of variances between the groups was rejected.